Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookDrugs Formulary for Health Center - Ethiopia (DACA; 2004; 222 pages)
View the documentACKNOWLEDGEMENTS
View the documentINTRODUCTION
Open this folder and view contentsGENERAL ADVICE TO PRESCRIBERS
Open this folder and view contents2. CARDIOVASCULAR DRUGS
Open this folder and view contents3. RESPIRATORY DRUGS
Open this folder and view contents4. CENTRAL NERVOUS SYSTEM DRUGS
Open this folder and view contents5. DRUGS USED IN ANESTHESIA
Open this folder and view contents6. DRUGS USED IN MUSCULOSKELETAL AND JOINT DISEASE
close this folder7. ANTI-INFECTIVE
Open this folder and view contents7.1. Antibacterials
View the document7.2. Antifungals
View the document7.3. Antiviral
close this folder7.4. Antiprotozoals
View the document7.4.1. Antimalarials
View the document7.4.2. Amoebicides and Antigiardial Agents
Open this folder and view contents7.5. Anthelmintics
Open this folder and view contents8. DRUGS USED IN ENDOCRINE DISORDERS AND CONTRACEPTIVES.
View the document9. OBSTETRIC AND GYNAECOLOGICAL MEDICATIONS
Open this folder and view contents10. BLOOD PRODUCTS AND DRUGS AFFECTING THE BLOOD
Open this folder and view contents11. DRUGS FOR CORRECTING WATER, ELECTROLYTE AND ACID - BASE DISTURBANCES
Open this folder and view contents12. VITAMINS
Open this folder and view contents13. ANTIHISTAMINES AND ANTIALLERGICS
Open this folder and view contents14. OPHTHALMIC AGENTS
Open this folder and view contents15. EAR, NOSE, AND THROAT PREPARATIONS
Open this folder and view contents16. DERMATOLOGIC AGENTS
View the document17. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING
View the document18. IMMUNOLOGICAL PREPARATIONS
View the document19. MISCELLANEOUS
View the documentAPPENDIXES
View the documentGLOSSARY
View the documentADVERSE DRUG REACTION REPORTING FORM
View the documentBACK COVER
 

7.4.2. Amoebicides and Antigiardial Agents

Metronidazole is a 5-nitroimidazole derivative with activity against protozoa and anaerobic bacteria. In amoebiasis, metronidazole acts as an amoebicide at all sites of infection with Entamoeba histolytica. Because of its rapid absorption it is probably less effective against parasites in the bowel lumen and is therefore used in conjunction with a luminal amoebicide such as diloxanide furoate or di-iodohydroxyquinoline in the treatment of amoebic dysentery and in extra-interstinal amoebiasis, including hepatic amoebiasis.

Tinidazole has the antimicrobial actions of metronidazole and usually administered as a single dose by mouth with or without food.

Metronidazole

Tablet, 250mg
Syrup 4% w/v, 250mg/5ml
Suspension (oral), 125mg/5ml
Intravenous infusion, 5mg/ml in 100ml

Indications: invasive amoebiasis and giardiasis, trichomoniasis, tissue nematode infections, bacterial infections (section 7.1.2); Helicobacter pylori eradication.

Cautions, Drug interactions, Contraindications, Side effects -see section 7.1.2 under metronidazole.

Dose and Administration

Invasive amoebiasis, by mouth, Adult and Child 30mg/kg daily in 3 divided doses for 8 - 10 days; subsequent course of luminal amoebicide.

Invasive amoebiasis; (if oral administration not possible), by intravenous infusion, Adult and patient able to complete course with oral drugs), subsequent course of luminal amoebicide.

Giardiasis, by mouth, Adult 2g once daily for 3 days, child 15mg/kg daily in divided doses for 5 - 10 days.

Storage - at room temperature, in a well closed, light resistant container.

Tinidazole

Tablet, 150mg, 500mg

Indications: - in the treatment of susceptible protozoal infections and in the treatment and prophylaxis of anaerobic bacterial infections.

Cautions: - see under metronidazole; avoid porphyria

Drug interactions: - alcohol

Side effects: - see under metronidazole

Dose and Administration: Oral

Intestinal amoebiasis, 2gm daily for 2 - 3 days; CHILD 50 - 60 mg/kg daily for 3 days

Amoebic involvement of liver, 1.5 - 2gm daily for 3 - 6 days, CHILD 50 - 60mg/kg daily for 5 days.

Giardiasis, single 2gm dose; CHILD single dose of 50 - 75 mg/kg (repeated once if necessary)

Diloxanide Furoate

Tablet, 500mg

Indications: - chronic amoebiasis, intestinal amoebiasis. It is a drug of choice for asymptomatic patients with E.histolytica cysts in the faces.

Side effects - flatulence, vomiting, urticaria, pruritus

Dose and Administration: -

Adult - oral, 500mg 3 times daily for 10 days
Child - oral, 20mg daily in 3 divided doses

to previous sectionto next section

Please provide your feedback English  |  French